Press Releases

As the American Society for Radiation Oncology gathers for its annual meeting, a radiation oncologist from Roswell Park is highlighting new evidence that a single dose, or “fraction,” of radiation therapy may be as effective as multiple radiotherapy treatments in addressing lung cancer tumors located centrally in the lung.

The Clinical Leukemia Service at Roswell Park helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML). The results of the KOMET-001 study, published today in The Lancet Oncology, show that the drug — part of a class of targeted therapies known as menin inhibitors — produced a partial or complete response in about a third of patients, all of whom had received two or more prior therapies.

Historically, some patients with blood cancers have been less likely than others to receive stem cell transplant, also known as bone marrow transplant. Theresa Hahn, PhD, of Roswell Park is lead author of a new study showing that older adults and Black patients are much less likely than people from other groups to receive a blood stem cell transplant.

A significant number of multiple myeloma patients may have an inherited but previously unrecognized risk of developing the disease, a new study led by Roswell Park Chief of Clinical Genomics Kenan Onel, MD, PhD, reveals.

A phase 1/2 clinical trial for patients with metastatic kidney cancer demonstrated that a novel two-agent treatment regimen developed at Roswell Park more than doubled progression-free survival compared with single-agent treatment. Saby George, MD, FACP, presented the findings at the European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain.

Roswell Park is pleased to be recognized again on Forbes’ Best Employers by State listing, ranked in the top 10 among New York State employers. Roswell Park is the only healthcare organization in Western New York to make this year’s list, and one of only two health employers in the top 10 for New York.

Hyundai Hope On Wheels awarded a $100,000 Hyundai Impact Award Grant to Roswell Park Comprehensive Cancer Center to continue its long-standing fight against pediatric cancer. The Hyundai Impact Award was presented to Kanwal Mallhi, MD.

A new collaboration will see Roswell Park Comprehensive Cancer Center partnering with the University of New Mexico (UNM), supported by a grant from the Bristol Myers Squibb Foundation, to address health disparities for the Pueblo Nations of New Mexico.